Solara Active Pharma Sciences
SOLARA
Solara Active Pharma Sciences Market Sentiment
| Timeline | Returns | Volume |
|---|---|---|
| Daily | - | 1,220 |
| Weekly | 10.81% | 4,23,649 |
| Monthly | 22.39% | 57,72,540 |
Solara Active Pharma Sciences Performance
| Timeline | Daily | Weekly | Monthly |
|---|---|---|---|
| SOLARA | - | 10.81% | 22.39% |
| Index | - | - | - |
| Peer Avg. | - | 5.43% | 11.51% |
Solara Active Pharma Sciences Fundamentals
| Timeline | PE | PB | EV/EBIDTA | ROE | ROCE | Div. Yield |
|---|---|---|---|---|---|---|
| SOLARA | 22.65 | 1.57 | -114.59 | -3.76 | -0.68 | - |
| Index | 35.44 | 5.98 | 16.81 | 16.99 | 18.41 | 1.19 |
| Peer Avg. | 39.55 | 4.75 | 12.35 | 13.59 | 17.02 | 0.87 |
Solara Active Pharma Sciences Key Metrics
| Metrics | Sales Growth | Profit Growth | ROE | ROCE |
|---|---|---|---|---|
| FY '21-22 | -21.56% | -126.42% | -3.76% | -0.68% |
| FY '20-21 | 22.33% | 94.86% | 17.18% | 15.31% |
| FY '19-20 | -6.16% | 92.25% | 12.34% | 11.64% |
Solara Active Pharma Sciences Shareholding Pattern
Solara Active Pharma Sciences Profit & Loss
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| FY '21-22 | 1,268.34 | 1,188.18 | 99.55 | -58.42 |
| FY '20-21 | 1,616.88 | 1,231.28 | 414.19 | 221.16 |
| FY '19-20 | 1,321.75 | 1,063.77 | 285.50 | 113.50 |
Solara Active Pharma Sciences Peer Comparison
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| SOLARA | 1,268.34 | 1,188.18 | 99.55 | -58.42 |
| ALEMBICLTD | 77.10 | 63.67 | 102.56 | 85.95 |
| IOLCP | 2,184.02 | 1,926.73 | 289.32 | 166.66 |
Solara Active Pharma Sciences Share Price
Solara Active Pharma Sciences Limited is an Indian company offering a wide range of commercial active ingredients (APIs) and contract manufacturing services in over 70 countries. The company operates through the API segment. Its commercial and R&D products include Albendazole, Aprepitant (Antiemetic), artesunate, brivaracetam (antiepileptic), Bumetanide (Inj) (Loop Diuretic), Buspirone HCL (Anxiolytic), Cetirizine Dihydrochloride, Chlorpromazine Hydrochloride, Cinacalcet Sodium (Cinacalcet Hydrochloride). Anticonvulsants), Colchicine (Antigout Agent), Colesevelam Hydrochloride, Cycloserine (Anti-Tuberculosis Agent), Ethacrynic acid (Cardiovascular System Support Agent), Hydralazine Hydrochloride (Hypertensive Agent), Ibuprofen Sodium Dihydrate (Anti-Inflammatory Agent), Mesna (Antineoplastic Detoxifying Agent), Mirabegron (treatment of OAB), pentoxifylline, etc. The company cooperates with North American, European and Japanese pharmaceutical companies.